Diet and Exercise Intervention for Breast Cancer

Not currently recruiting at 1 trial location
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Yale University
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether changes in diet and exercise can improve breast cancer treatment outcomes. Participants will split into two groups: one receiving usual care and the other receiving counseling to encourage healthier dietary choices and increased physical activity (Dietary/Physical Activity intervention). The goal is to determine if these lifestyle changes enhance treatment adherence, body composition, and key health markers. Women diagnosed with Stage I-III breast cancer who are about to start chemotherapy are ideal candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to understanding how lifestyle changes can support cancer treatment.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this dietary/physical activity intervention is safe for breast cancer patients?

Research has shown that combining exercise and a healthy diet can greatly improve the health of people with breast cancer. Studies have found that physical activity can lower the risk of death and reduce the chance of cancer recurrence.

Other studies indicate that individuals who eat well and exercise regularly tend to experience better health outcomes. These activities are generally safe, with most people not experiencing harmful side effects.

Overall, eating well and staying active are considered safe and beneficial for those undergoing breast cancer treatments.12345

Why are researchers excited about this trial?

Unlike the standard treatments for breast cancer, which often involve chemotherapy and endocrine therapy, the dietary and physical activity intervention emphasizes lifestyle changes to support recovery and overall health. This approach is unique because it integrates regular counseling sessions that encourage healthier eating habits and increased physical activity, personalized to fit into the patient's daily life. Researchers are excited about this treatment because it empowers patients to play an active role in their recovery process, potentially improving their quality of life and long-term health beyond traditional medical interventions.

What evidence suggests that this dietary and physical activity intervention is effective for breast cancer?

Research has shown that diet and exercise programs can improve the quality of life for breast cancer patients. In this trial, participants in the Dietary/Physical Activity Intervention arm will receive counseling sessions to motivate healthy dietary choices and physical activity. Studies have found that such programs can help reduce body fat by about 4 kg. Being active is also linked to a lower risk of cancer recurrence and death. Exercise can help maintain a healthy weight and improve heart and lung health. These findings suggest that adding diet and exercise to breast cancer treatment plans could be beneficial. Meanwhile, participants in the Usual Care Group will receive standardized breast cancer follow-up care and materials regarding treatment.45678

Who Is on the Research Team?

MI

Melinda Irwin, Ph.D.

Principal Investigator

Yale University

TS

Tara Sanft, M.D.

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for English-speaking women recently diagnosed with Stage I-III breast cancer who are about to start chemotherapy. They must be able to walk and follow the study's guidelines. Women can't join if they're pregnant, planning pregnancy, have had a stroke or heart failure in the past year, already follow similar health guidelines, or have completed their second chemo session.

Inclusion Criteria

Able to complete forms, understand instructions and read intervention book in English
I am scheduled for chemotherapy before or after surgery.
I agree to be randomly placed in a treatment or standard care group.
See 2 more

Exclusion Criteria

I follow recommended diet and exercise guidelines.
I have not had a stroke, heart attack, or severe heart failure in the past year.
Non-English speaking
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive neoadjuvant or adjuvant chemotherapy along with dietary and physical activity intervention

7 months
11 counseling sessions over 6 months, additional 5 sessions in latter 6 months

Follow-up

Participants are monitored for adherence to treatment, changes in biomarkers, body composition, diet, physical activity, and quality of life

5 years

Long-term Follow-up

Assessment of long-term outcomes such as quality of life and physical activity

5 years post-diagnosis

What Are the Treatments Tested in This Trial?

Interventions

  • Dietary/Physical Activity intervention
  • Usual Care
Trial Overview The study compares two approaches: one group will receive guidance on diet and exercise after their diagnosis (intervention), while the other will continue with their usual care without additional advice (control). The goal is to see how these strategies affect treatment adherence, body composition, and biomarkers.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Dietary/Physical Activity InterventionExperimental Treatment1 Intervention
Group II: Usual Care GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

A randomized trial involving 173 women with stage I-III breast cancer found that a home-based exercise and nutrition intervention improved diet quality and exercise levels but did not significantly affect the relative dose intensity (RDI) of chemotherapy compared to usual care.
However, the intervention was associated with a higher rate of pathologic complete response (pCR) in women receiving neoadjuvant chemotherapy, with 53% of those in the intervention group achieving pCR compared to 28% in the usual care group, indicating potential benefits for certain breast cancer subtypes.
Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study.Sanft, T., Harrigan, M., McGowan, C., et al.[2023]
The simultaneous stage-matched exercise and diet (SSED) intervention was found to be feasible and well-accepted among 45 breast cancer survivors, with 91% completing the trial and 100% receiving intervention calls.
Participants in the SSED group showed significant improvements in motivational readiness for exercise and diet, as well as better emotional functioning, reduced fatigue, and lower depression compared to the control group.
Randomized pilot test of a simultaneous stage-matched exercise and diet intervention for breast cancer survivors.Kim, SH., Shin, MS., Lee, HS., et al.[2022]
A lifestyle intervention involving diet and physical activity led to significant weight loss (5.6 kg) and improvements in body composition among 37 overweight and obese breast cancer survivors who completed the program.
Participants showed substantial reductions in energy and fat intake, along with improvements in quality of life and cardiorespiratory fitness, indicating the intervention's effectiveness in promoting healthier lifestyles post-treatment.
Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors.Travier, N., Fonseca-Nunes, A., Javierre, C., et al.[2021]

Citations

The Effects of Diet and Dietary Interventions on the Quality ...We performed a systematic review of nine experimental studies to summarize whether dietary interventions might improve QoL among breast cancer patients.
What are the most effective exercise, physical activity and ...Interestingly, we observed in the pairwise meta-analyses that diet and aerobic exercise interventions resulted in a reduction of ∼4.0 kg in fat ...
Outcomes of physical exercises on initiation, progression, and ...Evidence has suggested that participation in physical activity is correlated with a decrease in reappearance and fatality rates of breast cancer patients.
Cook and Move for Your Life, an eHealth intervention ...We tested the feasibility and preliminary efficacy of an online diet and physical activity program for women with early-stage breast cancer.
Breast Cancer Survivors' Diet and Physical Activity ...Current findings strongly suggest exercise interventions targeting BCS have desirable outcomes such as improved weight maintenance, cardiopulmonary functioning, ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40488447/
Effects of a Physical Activity mHealth Intervention (Fit2Thrive ...Results: The WCRF/AICR total score significantly improved at 12 and 24 weeks (P values < 0.001). MVPA improved at 12 and 24 weeks (P values < ...
Effects of Combined Interventions of Exercise and Diet or ...The main finding of this systematic review is that groups performing interventions combining exercise plus diet show significant improvements in ...
Association of Physical Activity With Risk of Mortality ...The findings of this cohort study suggest that even moderate physical activity was associated with a 60% lower risk of death among breast cancer ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security